HLA-C and cancer: The development of next-generation sequencing platforms and algorithms that predict epitope processing, MHC binding, and presentation enabled deeper dives into the cancer genome and immunopeptidome (Nielsen et al. 2003, Rammensee et al. 1999, Vita et al. 2015).